| Old Articles: <Older 40861-40870 Newer> |
|---|
 |
The Motley Fool
April 6, 2010
Brian Orelli |
Kill It! Double-Teaming Malaria Malaria vaccine might not make Glaxo and Crucell rich, but the life-saving and PR benefits would be welcome.   |
The Motley Fool
April 6, 2010
Selena Maranjian |
Have You Made The Riskiest Dividend Move? It might leave you with a paltry portfolio. Dividend investing may lack the dangers of penny-stock investing or day trading -- but it's not risk-free. |
The Motley Fool
April 6, 2010
John Rosevear |
How Far Will Toyota Go? Huge incentives have fueled a fast sales recovery. What happens when they end? |
The Motley Fool
April 6, 2010
Anders Bylund |
Was the iPad Launch a Triumph? With expectations ratcheted up sky-high, the iPad's early sales disappointed. |
The Motley Fool
April 6, 2010
David Lee Smith |
Is Oil's Upward March Inevitable? With an optimistic jobs report, crude prices seem to be heading higher. |
The Motley Fool
April 6, 2010
Chuck Saletta |
Can You Stop Buying Stocks? Probably not yet, but you can reach that point. |
The Motley Fool
April 6, 2010
Toby Shute |
Epic Fail by the Department of Energy? It turns out the government statistics were wrong. Oops. |
The Motley Fool
April 6, 2010
Rick Aristotle Munarriz |
Sirius XM's Quiet Before the Storm The satellite radio provider's been eerily silent. |
The Motley Fool
April 6, 2010
Dave Mock |
A Big Upgrade for Jacobs Engineering This bullish call comes from more than just one analyst. |
The Motley Fool
April 6, 2010
Jennifer Schonberger |
IMAX's CEO on Growth Opportunities Ahead Richard Gelfond talks about challenges and untapped potential. |
| <Older 40861-40870 Newer> Return to current articles. |
